SciTransfer
Organization

IUVO SRL

Italian wearable robotics company specializing in exoskeletons for industrial worker augmentation and clinical rehabilitation.

Engineering firmdigitalIT
H2020 projects
8
As coordinator
0
Total EC funding
€2.9M
Unique partners
92
What they do

Their core work

IUVO designs and develops wearable robotic systems — primarily exoskeletons and orthoprosthetic devices — for both industrial and rehabilitation applications. Based in Pontedera (Pisa area), they bring deep expertise in human-robot physical interaction, translating biomechanical research into functional wearable devices. Their work spans the full chain from benchmarking and standardization of robotic systems to deploying AI-assisted exoskeletons in manufacturing and clinical rehabilitation settings. They consistently serve as a specialist technology partner contributing exoskeleton hardware and human-centered interaction design to large European consortia.

Core expertise

What they specialise in

Wearable exoskeletons and orthoprosthesesprimary
6 projects

Central theme across CYBERLEGs Plus Plus, EUROBENCH, SHERLOCK, ReHyb, Mari4_YARD, and INBOTS — covering lower-limb prosthetics, industrial exoskeletons, and rehabilitation neuroprostheses.

Rehabilitation robotics and neuroprostheticsprimary
3 projects

ReHyb (largest funding at EUR 974K) focused on hybrid neuroprosthesis rehabilitation; CYBERLEGs Plus Plus on cognitive lower-limb orthoprostheses; CONBOTS on physical human coupling for motor learning.

3 projects

HUMAN (human-centric manufacturing), SHERLOCK (collaborative workplaces with exoskeletons and mobile robots), and Mari4_YARD (AI-assisted exoskeletons for shipyard workers).

Robotics benchmarking and standardizationsecondary
2 projects

EUROBENCH created European benchmarking framework for bipedal locomotion; INBOTS addressed inclusive robotics standards and societal integration.

AI-enabled wearable systems and digital twinsemerging
2 projects

ReHyb introduced digital twin approaches for rehabilitation; Mari4_YARD and SHERLOCK incorporated AI-enabled cognition and augmented reality into exoskeleton control.

Evolution & trajectory

How they've shifted over time

Early focus
Robotics benchmarking and standards
Recent focus
AI-assisted exoskeletons and rehabilitation

IUVO's early H2020 work (2016–2018) centered on foundational robotics — benchmarking wearable robots, standardizing testing for exoskeletons and humanoids, and establishing assessment methodologies through projects like EUROBENCH and INBOTS. From 2019 onward, their focus shifted decisively toward applied, intelligent systems: AI-assisted exoskeletons for workers, digital twin-based rehabilitation, and human-robot physical interaction for learning tasks. The trajectory shows a clear move from measuring and classifying robotic systems to deploying them in real-world industrial and clinical environments with embedded AI.

IUVO is moving toward intelligent, adaptive wearable robots that combine AI, digital twins, and augmented reality — expect their next projects to focus on personalized exoskeleton systems for healthcare and industry.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European22 countries collaborated

IUVO operates exclusively as a consortium partner — they have never coordinated an H2020 project, instead contributing specialized exoskeleton and wearable robotics expertise to larger teams. With 92 unique partners across 22 countries, they maintain a broad and non-repetitive collaboration network, suggesting they are sought after as a specialist contributor rather than building a closed circle of repeat collaborators. Their participation as a third party in SHERLOCK further confirms their role as a focused technology provider that larger consortia bring in for specific capabilities.

IUVO has collaborated with 92 distinct partners across 22 countries, giving them one of the broader networks you'd expect for a company of their size. Their base in Tuscany's robotics ecosystem (near Scuola Superiore Sant'Anna) likely anchors strong Italian connections, but their reach is thoroughly pan-European.

Why partner with them

What sets them apart

IUVO sits at a rare intersection: they combine deep expertise in wearable robotic hardware with practical experience deploying exoskeletons in both clinical rehabilitation and industrial manufacturing contexts. Most exoskeleton companies specialize in one domain; IUVO bridges the gap between medical neuroprosthetics and factory-floor worker augmentation. Their benchmarking background (EUROBENCH) also means they understand how to test and validate wearable robots against European standards — valuable for any consortium needing credible assessment of robotic performance.

Notable projects

Highlights from their portfolio

  • ReHyb
    Largest single funding (EUR 974K) — combines exoskeletons with digital twin technology for personalized rehabilitation, representing IUVO's most advanced applied work.
  • EUROBENCH
    Created the European benchmarking framework for bipedal locomotion — positions IUVO as a reference point for wearable robot testing and standardization.
  • Mari4_YARD
    Brings exoskeleton technology into shipbuilding — an unusual cross-sector application combining AI-assisted wearables with augmented reality for manual workers in shipyards.
Cross-sector capabilities
Manufacturing — AI-assisted exoskeletons for worker augmentation and ergonomic supportHealthcare/Rehabilitation — neuroprostheses and wearable devices for motor recoveryTransport — shipyard worker solutions combining robotics and AREducation — robotics for handwriting and music learning (motor skill transfer)
Analysis note: IUVO is likely a spin-off or closely affiliated with the BioRobotics Institute at Scuola Superiore Sant'Anna in Pontedera/Pisa. This academic connection is not in the data but would explain their strong benchmarking and research orientation. Listed as PRC but not SME, which is notable for a specialized robotics firm — they may have grown beyond SME thresholds or be structured differently. No website in the data limits independent verification.